Biosimilar Candidate A
Autoimmune Disorders (e.g., RA, Psoriasis)
Phase IIIActive
Key Facts
Indication
Autoimmune Disorders (e.g., RA, Psoriasis)
Phase
Phase III
Status
Active
About China Resources Pharmaceutical Group
CR Pharma's mission is to serve as a foundational pillar of China's national healthcare system through its integrated pharmaceutical platform. Its key achievements include establishing one of the country's largest distribution networks, a significant manufacturing base, and an extensive retail pharmacy chain under the CRCare brand. The company's strategy is centered on vertical integration, leveraging its state-backed position to consolidate market share, control supply chains, and commercialize products from its R&D pipeline across key therapeutic areas. This approach aims to secure sustainable growth amid government-led volume-based procurement and an aging population.
View full company profile